| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 313 |
| 1 | EPOPROSTENOL | 302 |
| 2 | SILDENAFIL CITRATE | 268 |
| 3 | TADALAFIL | 238 |
| 4 | MACITENTAN | 215 |
| 5 | AMBRISENTAN | 209 |
| 6 | SILDENAFIL | 171 |
| 7 | FUROSEMIDE | 117 |
| 8 | SILDENAFIL POWDER, | 99 |
| 9 | 0XYGEN | 89 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 302 | 0.0230 |
| 1 | FOSCARBIDOPA/FOSLEVODOPA | 79 | 0.0090 |
| 2 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 4 | 0.0051 |
| 3 | MACITENTAN | 215 | 0.0031 |
| 4 | MIDODRINE HYDROCHLORIDE | 13 | 0.0029 |
| 5 | SILDENAFIL POWDER, | 99 | 0.0028 |
| 6 | TREPROSTINIL | 313 | 0.0024 |
| 7 | TADALAFIL | 238 | 0.0024 |
| 8 | RIOCIGUAT | 72 | 0.0022 |
| 9 | SILDENAFIL CITRATE | 268 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 589 |
| 1 | Endothelin Receptor Antagonist [EPC] | 414 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 321 |
| 3 | Loop Diuretic [EPC] | 158 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 114 |
| 5 | Osmotic Laxative [EPC] | 107 |
| 6 | Aldosterone Antagonist [EPC] | 88 |
| 7 | Corticosteroid [EPC] | 84 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 72 |
| 9 | Benzodiazepine [EPC] | 57 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 589 | 0.0043 |
| 1 | Interferon gamma Blocker [EPC] | 1 | 0.0042 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 321 | 0.0024 |
| 3 | Soluble Guanylate Cyclase Stimulator [EPC] | 72 | 0.0021 |
| 4 | Endothelin Receptor Antagonist [EPC] | 414 | 0.0021 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 9 | 0.0018 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 37 | 0.0014 |
| 7 | Autologous Cellular Immunotherapy [EPC] | 8 | 0.0014 |
| 8 | GLP-2 Analog [EPC] | 15 | 0.0011 |
| 9 | Prostacycline [EPC] | 1 | 0.0011 |